MHRA approves new diagnostic agent for adult patients showing signs of cognitive impairment for Alzheimer’s disease

  • Post author:
  • Post category:

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 27 November 2024, approved the medicine flortaucipir (Tauvid), a radiopharmaceutical product given to adults with memory problems so that doctors…

Continue ReadingMHRA approves new diagnostic agent for adult patients showing signs of cognitive impairment for Alzheimer’s disease

New chair of the MHRA

  • Post author:
  • Post category:

Anthony Harnden has been appointed as the new chair of the Medicine and Healthcare products Regulatory Agency (MHRA).Anthony is a Professor of Primary Care at the University of Oxford, and…

Continue ReadingNew chair of the MHRA

The MHRA seeks views on pre-market regulations for medical devices to improve patient access and strengthen patient safety

  • Post author:
  • Post category:

A consultation has been launched by the Medicines and Healthcare products Regulatory Agency (MHRA) on proposed changes to the regulatory requirements a medical device must meet before it is placed…

Continue ReadingThe MHRA seeks views on pre-market regulations for medical devices to improve patient access and strengthen patient safety